Letter to the editor concerning first-line therapy with afatinib - an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations.
| Image |  |
|---|---|
| Description | scientific article published on 8 July 2015 |
| Author/s |
author: Paweł Krawczyk Tomasz Powrózek Janusz Milanowski Marcin Nicos |
| Publication date | July 8, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |